The modifying effects of HS-CRP on the association between blood pressure and stroke risk in a non-hypertensive

Fanghua Liu1, Xiaowei Zheng2, Suwen Shen3

  • 1The First Department of Chronic Disease Prevention and Control, Baoshan District Center for Disease Control and Prevention, Shanghai, 201901, China.

Insights

High-sensitivity C-reactive protein (HS-CRP) modifies the association between normal blood pressure (BP) and stroke risk. Elevated BP in individuals with high HS-CRP levels, but not low levels, significantly increased stroke risk.

Area of Science:

  • Cardiovascular Epidemiology
  • Biomarkers and Disease Risk
  • Preventive Cardiology

Background:

  • Blood pressure (BP) and high-sensitivity C-reactive protein (HS-CRP) are known stroke risk factors.
  • The combined impact of BP and HS-CRP on stroke risk in normotensive individuals is not well understood.

Purpose of the Study:

  • To investigate the role of HS-CRP in modifying the relationship between BP and stroke risk.
  • To examine this association in a Chinese adult population without hypertension.

Main Methods:

  • Analysis of 4509 Chinese adults aged ≥45 years from the China Health and Retirement Longitudinal Study (CHARLS).
  • Baseline BP and HS-CRP levels were measured, with stroke events tracked over 9 years.
  • Multivariate Cox proportional hazards regression models were used to assess stroke risk, stratified by HS-CRP levels.

Main Results:

  • Elevated systolic BP (SBP), diastolic BP (DBP), and mean arterial pressure (MAP) were associated with increased stroke risk only in participants with high HS-CRP levels.
  • Linear dose-response relationships were observed between higher BP and stroke risk among those with high HS-CRP.
  • No significant association between elevated BP and stroke risk was found in individuals with low HS-CRP levels.

Conclusions:

  • High HS-CRP levels appear to potentiate the risk of stroke associated with elevated normal BP.
  • HS-CRP may serve as a crucial biomarker in identifying normotensive individuals at higher risk of stroke due to elevated BP.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
48
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Factors affecting Blood pressure01:28

Factors affecting Blood pressure

Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
4.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
213
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
77